Board approves ESOP allotment and reappointment of two Independent Directors

Board & Shareholder Meetings View source PDF

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.8%1-day move

₹1180.00

prior close

₹1178.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.8-0.8-1.1-0.4+0.8+0.4+1.3+2.7+0.8+0.0+1.7———

Up moveDown movePending

AI summary

Entero Healthcare's board, on June 26 2026, approved allotment of 1,475 equity shares of Rs 10 face value under the ESOP 2023 at an exercise price of Rs 804 per share. Total issued shares now stand at about 4.35 crore. The board also approved revised tenure for reappointment of Mr Rajesh Shashikant Dalal and Ms Sandhya Gadkari Sharma as Non-Executive Independent Directors for a second term of 4 years (Aug 25 2026 to Aug 24 2030), subject to shareholder approval at the upcoming AGM.

Likely market impact

Minor dilution from ESOP allotment of 1,475 shares. Reappointments of two independent directors need shareholder nod at AGM. Neutral for stock.